GEODE CAPITAL MANAGEMENT, LLC - ARENA PHARMACEUTICALS INC ownership

ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 1 filers reported holding ARENA PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of ARENA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2017$2,739,000
+9.8%
1,876,137
+6.8%
0.00%0.0%
Q4 2016$2,494,000
-16.8%
1,756,801
+2.6%
0.00%
-50.0%
Q3 2016$2,996,000
+3.4%
1,712,260
+1.0%
0.00%0.0%
Q2 2016$2,898,000
-12.0%
1,695,179
+1.3%
0.00%0.0%
Q1 2016$3,295,000
+12.0%
1,672,885
+8.0%
0.00%0.0%
Q4 2015$2,942,000
+1.3%
1,549,235
+1.9%
0.00%0.0%
Q3 2015$2,903,000
-58.8%
1,520,222
+0.2%
0.00%
-50.0%
Q2 2015$7,038,000
+8.2%
1,516,926
+1.9%
0.00%0.0%
Q1 2015$6,505,000
+45.4%
1,488,601
+15.5%
0.00%
+33.3%
Q4 2014$4,473,000
-14.8%
1,289,246
+2.9%
0.00%0.0%
Q3 2014$5,250,000
-29.0%
1,253,163
-0.8%
0.00%
-40.0%
Q2 2014$7,399,000
-3.8%
1,262,732
+3.5%
0.01%0.0%
Q1 2014$7,688,000
+22.0%
1,220,413
+13.2%
0.01%
+25.0%
Q4 2013$6,304,000
+20.3%
1,077,683
+8.3%
0.00%0.0%
Q3 2013$5,242,000
-26.0%
994,639
+8.1%
0.00%
-33.3%
Q2 2013$7,084,000919,9470.01%
Other shareholders
ARENA PHARMACEUTICALS INC shareholders Q2 2017
NameSharesValueWeighting ↓
Camber Capital Management LP 9,750,000$18,623,0001.60%
DAFNA Capital Management LLC 381,600$729,0000.72%
SENZAR ASSET MANAGEMENT, LLC 1,766,991$3,374,953,0000.49%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 4,640,877$8,864,0000.34%
Lyons Wealth Management, LLC. 56,665$110,0000.14%
FEDERATED HERMES, INC. 5,648,920$10,789,0000.04%
WELLINGTON MANAGEMENT GROUP LLP 33,909,459$64,767,0000.02%
Cubist Systematic Strategies, LLC 185,166$354,0000.02%
GAM Holding AG 523,164$997,0000.02%
STEVENS CAPITAL MANAGEMENT LP 191,236$365,0000.02%
View complete list of ARENA PHARMACEUTICALS INC shareholders